1. Gutowska-Œlesik J, Samoliñski B, Krzych-Fa³ta E. The increase in allergic conditions based on a review of literature. Adv Dermatol Allerg 2023; 40: 1-7.
2.
£oœ-Rycharska E, Go³êbiewski M, Sikora M, et al. A combined analysis of gut and skin microbiota in infants with food allergy and atopic dermatitis: a pilot study. Nutrients 2021; 13: 1682.
3.
Kaziród-Wolski K, Zabojszcz M, Jaskulska P, et al. Allergic reactions during coronary angiography or PCI in Poland: occurrence, trends and predictors. Long-term perspective based on ORPKI registry. Pol Heart J 2025; 83: 313-20.
4.
Kar³owicz-Bodalska K, Janicka N, Oœliz³o M, et al. Novel approach: diphenhydramine and lidocaine combination therapy for alleviating inflammatory and allergic skin conditions with coexisting itch. Pol Pharm J 2024; 81: 203-14.
5.
Magierska A, Ptak O, Szczepaniak Z, et al. Exacerbation of atopic dermatitis skin lesions in SARS-CoV-2 disease. Adv Dermatol Allergol 2022; 39: 998-1000.
6.
Beck LA, Cork MJ, Amagai M, et al. Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis. JID Innov 2022; 2: 100131.
7.
Jafarzadeh A, Naseri A, Shojaie L, et al. MicroRNA-155 and antiviral immune responses. Inter Immunop 2021; 101: 108188.
8.
Bacharier LB, Jackson DJ. Biologics in the treatment of asthma in children and adolescents. J Aller Clin Immun 2023; 151: 581-9.
9.
Bacharier LB, Jackson DJ. Therapeutic monoclonal antibodies in allergy: targeting IgE, cytokine, and alarmin pathways. Immun Rev 2024; 328: 387-411.
10.
McCraw AJ, Chauhan J, Bax HJ, et al. Insights from IgE immune surveillance in allergy and cancer for anti-tumour IgE treatments. Cancers 2021; 13: 4460.
11.
Akdis CA, Arkwright PD, Brüggen MC, et al. Type 2 immunity in the skin and lungs. Allergy 2020; 75: 1582-605.
12.
Peng Y, Tao Y, Zhang Y, et al. CD25: A potential tumor therapeutic target. Int J Can 2023; 152: 1290-303.
13.
Constantinides MG, Belkaid Y. Early-life imprinting of unconventional T cells and tissue homeostasis. Science 2021; 374: eabf0095.
14.
Lee HJ, Kim M. Skin barrier function and the microbiome. Int J Mol Scien 2022; 23: 13071.
15.
Criado PR, Miot HA, Ianhez M. Eosinophilia and elevated IgE serum levels: a red flag: when your diagnosis is not a common atopic eczema or common allergy. Inflamm Res 2023; 72: 541-51.
16.
de Boer FL, van der Molen HF, Kezic S. Epidermal biomarkers of the skin barrier in atopic and contact dermatitis. Contact Derm 2023; 89: 221-9.
17.
Larenas-Linnemann D. Biomarkers of autoimmune chronic spontaneous urticaria. Cur Aller Asthma Rep 2023; 23: 655-64.
18.
Gunduz O, Modi D, Duarte R. The role of epidermal differentiation gene complex studies in atopic dermatitis. Turk Arch Derm Vener 2021; 55: 56-61.
19.
Gorelick J, Nguyen A, Schneider SKR, et al. Biomarkers in atopic dermatitis: a review of the role of IL-13 and the impact of tralokinumab treatment. Am J Clin Dermatol 2025; 26: 199-211.
20.
Laska J, Tota M, £acwik J, et al. IL-22 in atopic dermatitis. Cells 2024; 13: 1398.
21.
Mastraftsi S, Vrioni G, Bakakis M, et al. Atopic dermatitis: striving for reliable biomarkers. J Clin Med 2022; 11: 4639.
22.
Kim Y, Lim KM. Skin barrier dysfunction and filaggrin. Arch Pharm Res 2021; 44: 36-48.
23.
Ogulur I, Pat Y, Ardicli O, et al. Advances and highlights in biomarkers of allergic diseases. Allergy 2021; 76: 3659-86.
24.
Fatima I, Uppada JP, Chhonker YS, et al. Identification and characterization of a first-generation inhibitor of claudin-1 in colon cancer progression and metastasis. Biomed Pharmacother 2023; 159: 114255.
25.
Ishitsuka Y, Roop DR. Loricrin at the boundary between inside and outside. Biomolecules 2022; 12: 673.
26.
Pitlick MM, Pongdee T. Combining biologics targeting eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in allergic and inflammatory diseases. World Allergy Organ J 2022; 15: 100707.
27.
Basheer S, Shaalan SH, Rahem NN, et al. Effects of IL-4, IL-5, and IL-13 on total and allergy specific IgE production in patients with allergic rhinitis. Aip Conf Proc 2023; 2839: 080008.
28.
Bao Y, Zhu X. Role of chemokines and inflammatory cells in respiratory allergy. J Asthma Aller 2022; 15: 1805-22.
29.
Baumann R, Untersmayr E, Zissler UM, et al. Non-invasive and minimally invasive techniques for the diagnosis and management of allergic diseases. Allergy 2020; 76: 1010-23.
30.
Akdis CA, Akdis M, Boyd SD, et al. Allergy: mechanistic insights into new methods of prevention and therapy. Sci Transl Med 2023; 15: eadd2563.
31.
Satam H, Joshi K, Mangrolia U, et al. Next-generation sequencing technology: current trends and advancements. Biology 2023; 12: 997.
32.
Kasianchuk N, Dobrowolska K, Harkava S, et al. Gene-editing and RNA interference in treating hepatitis B: a review. Viruses 2023; 15: 2395.
33.
Cameli N, Silvestri M, Mariano M, et al. Allergic contact dermatitis, an important skin reaction in diabetes device users: a systematic review. Dermatitis 2022; 33: 110-5.
34.
Livshits G, Kalinkovich A. Resolution of chronic inflammation, restoration of epigenetic disturbances and correction of dysbiosis as an adjunctive approach to the treatment of atopic dermatitis. Cells 2024; 13: 1899.
35.
Dubin C, Del Duca E, Guttman-Yassky E. The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Exp Rev Clin Immun 2021; 17: 835-52.
36.
Donetti E, Riva F, Indino S, et al. Th2 cytokines affect the innate immune barrier without impairing the physical barrier in a 3D model of normal human skin. J Clin Med 2023; 12: 1941.
37.
Katsarou S, Makris M, Vakirlis E, et al. The role of tight junctions in atopic dermatitis: a systematic review. J Clin Med 2023; 12: 1538.
38.
Dong S, Li D, Shi D. Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition. Front Med 2024; 11: 1335551.
39.
Namrata K, Bai BX. Role of tight junctions and their protein expression in atopic dermatitis. Int J Derm Venereol 2021; 4: 40-4.
40.
Guo Y, Wang L, Zhang J, et al. In vitro study of momordin Ic in improving atopic dermatitis by regulating Claudin-1/MyD88 and targeting NLRP3. Pol Pharm J 2024; 81: 309-17.
41.
Săsăran MO, Melit LE, Dobru ED. MicroRNA modulation of host immune response and inflammation triggered by Helicobacter pylori. Int J Mol Sci 2021; 22: 1406.
42.
Kim M, Jo H, Kwon Y, et al. MiR-154-5p-MCP1 axis regulates allergic inflammation by mediating cellular interactions. Front Immunol 2021; 12: 663726.
43.
Hammad NM, Nabil F, Elbehedy EM, et al. Role of microRNA-155 as a potential biomarker for allergic rhinitis in children. Canad Resp J 2021; 2021: 5554461.
44.
Tontini C, Bulfone-Paus S. Novel approaches in the inhibition of IgE-induced mast cell reactivity in food allergy. Front Immunol 2021; 12: 613461.
45.
Tubau C, Puig L. Therapeutic targeting of the IL-13 pathway in skin inflammation. Exp Rev Clin Immun 2021; 17: 15-25.
46.
Napolitano M, di Vico F, Ruggiero A, et al. The hidden sentinel of the skin: an overview on the role of interleukin-13 in atopic dermatitis. Front Med 2023; 10: 1165098.
47.
Yamaguchi HL, Yamaguchi Y, Peeva E. Role of innate immunity in allergic contact dermatitis: an update. Int J Mol Sci 2023; 24: 12975.
48.
Khosrojerdi M, Azad FJ, Yadegari Y, et al. The role of microRNAs in atopic dermatitis. Noncoding RNA Res 2024; 9: 1033-9.
